Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
| Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections. | Front Immunol | 2022 | 36016956 | PubTator, text mining | PubMed |
| Altered HIV-1 Viral Copy Number and Gene Expression Profiles of Peripheral (CEM CCR5+) and Mucosal (A3R5.7) T Cell Lines Co-Infected with HSV-2 In Vitro. | Viruses | 2022 | 36016337 | PubTator, text mining | PubMed |
| The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer. | Int J Mol Sci | 2022 | 36012588 | PubTator, text mining | PubMed |
| TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer. | Cancers (Basel) | 2022 | 36011046 | PubTator, text mining | PubMed |
| The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. | Signal Transduct Target Ther | 2022 | 36008393 | PubTator, text mining | PubMed |
| High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. | BMC Bioinformatics | 2022 | 35996075 | PubTator, text mining | PubMed |
| X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer. | Front Genet | 2022 | 35991556 | PubTator, text mining | PubMed |
| A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer. | Front Immunol | 2022 | 35990656 | PubTator, text mining | PubMed |
| A LIGHT-HVEM/LTβR axis contributes to the fibrosis of intrauterine adhesion. | J Reprod Immunol | 2022 | 35987137 | PubTator, text mining | PubMed |
| Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy. | Front Immunol | 2022 | 35983053 | PubTator, text mining | PubMed |
| Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study. | Front Immunol | 2022 | 35979348 | PubTator, text mining | PubMed |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts. | J Hematol Oncol | 2022 | 35978433 | PubTator, text mining | PubMed |
| Peptide therapeutics in the management of metastatic cancers. | RSC Adv | 2022 | 35975072 | PubTator, text mining | PubMed |
| Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas. | Hemasphere | 2022 | 35974958 | PubTator, text mining | PubMed |
| Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients. | J Virol | 2022 | 35969080 | PubTator, text mining | PubMed |
| [Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35968589 | PubTator, text mining | PubMed |
| Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers. | Front Oncol | 2022 | 35965554 | PubTator, text mining | PubMed |
| Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma. | BMC Cancer | 2022 | 35964070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=53